Additionally, while the total discontinuation rates were not reported, the proportion of patients receiving active treatment who discontinued due to adverse events was 10% in the LEADER trial of liraglutide (median follow-up 46 months) and 12% in the PIONEER 6 trial of oral semaglutide (median follow-up 15.9 months)
Which companies will benefit from those trends, besides the ones producing the drugs
It appears that High Curler has emphasized large companies as all the usuals are present
As a template for real-time PCR, 0.39 L of cDNA was amplified in 5 L final volume
Among patients on obesity indications, 66.5 percent remained in retail pharmacy channels after one year, meaning roughly a third did not
The concentrations of protein extracts were determined by using the BCA Protein Assay Kit (Thermo Fisher Cat #23225), then protein samples were mixed with 3 loading buffer and loaded in equal amounts into the wells of 412% Bis-Tris protein gels (Bio-Rad) to transfer the proteins to PVDF membranes (Millipore)